| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allocating scarce intensive care resources during the COVID-19 pandemic: practical challenges to theoretical frameworks
|
Supady, Alexander
|
|
|
9 |
4 |
p. 430-434
|
artikel
|
| 2 |
α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action
|
Yang, Chengliang
|
|
|
9 |
4 |
p. 337-339
|
artikel
|
| 3 |
A tribute to the gang
|
Roman, Jesse
|
|
|
9 |
4 |
p. 345-346
|
artikel
|
| 4 |
Bearing witness in the time of COVID
|
Ramkumar, Mukund
|
|
|
9 |
4 |
p. 347-348
|
artikel
|
| 5 |
Challenges in the rollout of COVID-19 vaccines worldwide
|
Burki, Talha Khan
|
|
|
9 |
4 |
p. e42-e43
|
artikel
|
| 6 |
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
|
Ranzani, Otavio T
|
|
|
9 |
4 |
p. 407-418
|
artikel
|
| 7 |
Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial
|
Clark, Tristan W
|
|
|
9 |
4 |
p. 419-429
|
artikel
|
| 8 |
Correction to Lancet Respir Med 2021; 9: 85–95
|
|
|
|
9 |
4 |
p. e38
|
artikel
|
| 9 |
Correction to Lancet Respir Med 2021; published online Feb 10. https://doiorg/10.1016/S2213-2600(20)30510-5
|
|
|
|
9 |
4 |
p. e38
|
artikel
|
| 10 |
Correction to Lancet Respir Med 2021; published online Jan 28. https://doi.org/10.1016/S2213-2600(20)30517-8
|
|
|
|
9 |
4 |
p. e38
|
artikel
|
| 11 |
COVID-19 in the Caribbean
|
Burki, Talha Khan
|
|
|
9 |
4 |
p. e46
|
artikel
|
| 12 |
Critical care trainees call for pulse oximetry reform
|
Hidalgo, Daniel Colon
|
|
|
9 |
4 |
p. e37
|
artikel
|
| 13 |
Delayed-onset myocarditis following COVID-19
|
Bajaj, Retesh
|
|
|
9 |
4 |
p. e32-e34
|
artikel
|
| 14 |
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
|
Gupta, Rishi K
|
|
|
9 |
4 |
p. 349-359
|
artikel
|
| 15 |
Ethics and evidence: learning lessons from pandemic triage
|
Wilkinson, Dominic J C
|
|
|
9 |
4 |
p. 328-330
|
artikel
|
| 16 |
Face masks: all for one and one for all
|
The Lancet Respiratory Medicine,
|
|
|
9 |
4 |
p. 319
|
artikel
|
| 17 |
Face masks in the post-COVID-19 era: a silver lining for the damaged tuberculosis public health response?
|
Driessche, Koen Vanden
|
|
|
9 |
4 |
p. 340-342
|
artikel
|
| 18 |
Geography, generalisability, and susceptibility in clinical trials
|
Clougherty, Jane E
|
|
|
9 |
4 |
p. 330-332
|
artikel
|
| 19 |
Highlights of the 11th International Cough Symposium
|
Geraldes, Flávia Oliveira
|
|
|
9 |
4 |
p. e40-e41
|
artikel
|
| 20 |
High oxygen flow rates with the UCL Ventura CPAP device
|
Kempley, Stephen
|
|
|
9 |
4 |
p. e35
|
artikel
|
| 21 |
High oxygen flow rates with the UCL Ventura CPAP device – Authors' reply
|
Singer, Mervyn
|
|
|
9 |
4 |
p. e36
|
artikel
|
| 22 |
How could we forget?
|
Ramchandran, Kavitha
|
|
|
9 |
4 |
p. 346-347
|
artikel
|
| 23 |
Improving clinical management of COVID-19: the role of prediction models
|
Wynants, Laure
|
|
|
9 |
4 |
p. 320-321
|
artikel
|
| 24 |
Improving family access to dying patients during the COVID-19 pandemic
|
Downar, James
|
|
|
9 |
4 |
p. 335-337
|
artikel
|
| 25 |
Living with bronchiectasis during the COVID-19 pandemic
|
Williamson, Lucy
|
|
|
9 |
4 |
p. 343-344
|
artikel
|
| 26 |
Nebulised heparin for patients on ventilation: implications for COVID-19 pneumonia
|
Ball, Lorenzo
|
|
|
9 |
4 |
p. 321-322
|
artikel
|
| 27 |
Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
|
Dixon, Barry
|
|
|
9 |
4 |
p. 360-372
|
artikel
|
| 28 |
Oxygen supplies and COVID-19 mortality in Africa
|
Nakkazi, Esther
|
|
|
9 |
4 |
p. e39
|
artikel
|
| 29 |
Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: an observational study using administrative data
|
Navaratnam, Annakan V
|
|
|
9 |
4 |
p. 397-406
|
artikel
|
| 30 |
Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial
|
Day, Tracey A
|
|
|
9 |
4 |
p. 373-386
|
artikel
|
| 31 |
SARS-CoV-2 evolution and vaccines: cause for concern?
|
Williams, Thomas C
|
|
|
9 |
4 |
p. 333-335
|
artikel
|
| 32 |
Should we ration extracorporeal membrane oxygenation during the COVID-19 pandemic?
|
Supady, Alexander
|
|
|
9 |
4 |
p. 326-328
|
artikel
|
| 33 |
Trajectories of asthma and allergies from 7 years to 53 years and associations with lung function and extrapulmonary comorbidity profiles: a prospective cohort study
|
Bui, Dinh S
|
|
|
9 |
4 |
p. 387-396
|
artikel
|
| 34 |
Trends in COVID-19-related in-hospital mortality: lessons learned from nationwide samples
|
Madahar, Purnema
|
|
|
9 |
4 |
p. 322-324
|
artikel
|
| 35 |
Trial participants' rights after authorisation of COVID-19 vaccines
|
Dal-Ré, Rafael
|
|
|
9 |
4 |
p. e30-e31
|
artikel
|
| 36 |
Use of point-of-care testing for respiratory viruses in hospital
|
Hayward, Andrew C
|
|
|
9 |
4 |
p. 324-326
|
artikel
|
| 37 |
When should the UK lift its lockdown?
|
Kirby, Tony
|
|
|
9 |
4 |
p. e44-e45
|
artikel
|
| 38 |
Yemen: Coronavirus in a War Zone
|
Burki, Talha Khan
|
|
|
9 |
4 |
p. 343
|
artikel
|
Tijdschrift beschrijving